MAPT and Alzheimer disease: Activated microglia, which can be detected via fluid biomarkers such as sTREM2 or YKL-40 and via TSPO PET imaging, are key drivers of synaptic dysfunction, tau phosphorylation, and neuronal loss in AD [57].